Suppr超能文献

黄酮类化合物对 P-糖蛋白的体外和体内抑制作用:食物/药物相互作用和构效关系。

Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships.

机构信息

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Drug Metabolism, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China.

出版信息

Toxicol Appl Pharmacol. 2019 Apr 15;369:49-59. doi: 10.1016/j.taap.2019.02.010. Epub 2019 Feb 19.

Abstract

Flavonoids are a class of polyphenol antioxygen, despite various known biological activities and therapeutic potential, scattered but not much is known about their interactions with drug transporters. P-glycoprotein (P-gp) as a cellular defense mechanism by effluxing its substrates has been widely investigated. The aim of this study was to investigate the inhibitory effects of 75 flavonoids on P-gp in vitro and in vivo and to illuminate the structure-activity relationships of flavonoids with P-gp. Five flavonoids, including tangeretin, sinensetin, isosinensetin, sciadopitysin and oroxylin A exhibited significant inhibition on P-gp in MDR1-MDCKIIcells, which reduced the P-gp-mediated efflux of paraquat and taxol and consequently increased their cell toxicity. In addition, co-administration of digoxin with five flavonoids increased the AUC of digoxin in different extents in rats, from 19.84% to 81.51%. Molecular docking assays elucidated the inhibitory effect of flavonoids might be related to Pi interactions, but not hydrogen bonds. The pharmacophore model suggested the hydrophobic groups in B benzene ring may play a vital role in the potency of flavonoids inhibition on P-gp. Taken together, our findings would provide the basis for a reliable assessment of the potential risks of flavonoid-containing food/herb-drug interactions in humans.

摘要

类黄酮是一类多酚抗氧化剂,尽管具有各种已知的生物活性和治疗潜力,但它们与药物转运蛋白的相互作用却知之甚少。P 糖蛋白(P-gp)作为一种通过外排其底物的细胞防御机制已被广泛研究。本研究旨在研究 75 种类黄酮在体外和体内对 P-gp 的抑制作用,并阐明类黄酮与 P-gp 的结构-活性关系。五种类黄酮,包括桔皮素、橙皮素、异橙皮素、裂环烯醚萜和山奈酚 A,在 MDR1-MDCKII 细胞中对 P-gp 表现出显著的抑制作用,减少了 P-gp 介导的对百草枯和紫杉醇的外排,从而增加了它们的细胞毒性。此外,在大鼠中,地高辛与五种类黄酮同时给药在不同程度上增加了地高辛的 AUC,从 19.84%增加到 81.51%。分子对接实验阐明了类黄酮的抑制作用可能与 Pi 相互作用有关,而不是氢键。药效团模型表明,B 苯环中的疏水区段可能在类黄酮抑制 P-gp 的效力中发挥重要作用。综上所述,我们的研究结果为评估含类黄酮的食物/草药-药物相互作用对人类的潜在风险提供了可靠的依据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验